Beat to Beat A Study in Paediatric, Adolescent and Young Adult Patients Who Are Undergoing or Have Undergone Cancer Therapy to Evaluate the Agreement Between QTc Measured Using 12 Lead Electrocardiogram (ECG) and a Wearable Device ECG
Phase NA Completed
45 enrolled
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Completed
1,149 enrolled
PTN_POPS
Completed
3,520 enrolled
Clearance Of Mucus In Stents (COMIS)
Phase NA Completed
43 enrolled
ACTIV4
Completed
3,554 enrolled
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Completed
1,149 enrolled
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Completed
4,626 enrolled
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Completed
361 enrolled
OPTI-AGED
Phase NA Completed
2,495 enrolled
ARBITRAGE
Completed
1,717 enrolled
Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method
Phase 4 Completed
50 enrolled 6 charts
atropinePEI
Phase 4 Completed
31 enrolled